中国医疗保险
中國醫療保險
중국의료보험
CHINA HEALTH INSURANCE
2013年
9期
59-61
,共3页
医疗保险%门诊药品%使用情况
醫療保險%門診藥品%使用情況
의료보험%문진약품%사용정황
medical insurance%outpatient pharmacy%usage
通过对福建省医疗保险管理中心铁路分中心,近3年第一季度定点医院的门诊西药、中成药使用数据分析,发现循环系统用药、激素及调节内分泌功能类药、祛瘀剂(理血剂)金额占比居前3位,约占药品总额47%;门诊慢性病用药集中度高,常用药品为抗高血压药、降血糖药、调节血脂药。建议将长期治疗、费用较高的重大疾病或慢性病优先纳入门诊统筹;除特殊病种以外的门诊费用纳入普通病种统筹适度保障。
通過對福建省醫療保險管理中心鐵路分中心,近3年第一季度定點醫院的門診西藥、中成藥使用數據分析,髮現循環繫統用藥、激素及調節內分泌功能類藥、祛瘀劑(理血劑)金額佔比居前3位,約佔藥品總額47%;門診慢性病用藥集中度高,常用藥品為抗高血壓藥、降血糖藥、調節血脂藥。建議將長期治療、費用較高的重大疾病或慢性病優先納入門診統籌;除特殊病種以外的門診費用納入普通病種統籌適度保障。
통과대복건성의료보험관리중심철로분중심,근3년제일계도정점의원적문진서약、중성약사용수거분석,발현순배계통용약、격소급조절내분비공능류약、거어제(리혈제)금액점비거전3위,약점약품총액47%;문진만성병용약집중도고,상용약품위항고혈압약、강혈당약、조절혈지약。건의장장기치료、비용교고적중대질병혹만성병우선납입문진통주;제특수병충이외적문진비용납입보통병충통주괄도보장。
According to the analysis of the data of the outpatient pharmacy and Chinese medicine prescribed during the first season of the last three years in the Medical Insurance Management Center of Railway Branch in Fujian province, we found that cardiovascular drugs, hormone and endocrine function regulating medicines, and medicines promoting blood circulation and removing blood stasis take the top three position by usage amount, accounting for about 47%of the total drug. Chronic disease drugs, including anti-hypertensives, hypoglycemic agents, blood lipid-lowering drugs, are often used concentratively. We suggest that serious diseases and chronic diseases which need a long-term treatment and a higher cost should be brought into patient co-ordination priorly. Outpatient costs, except those for special diseases, are included into general diseases and given moderate guarantee.